Marshall Wace
ZVRA icon

Marshall Wace’s Zevra Therapeutics ZVRA Stock Holding History

Marshall Wace’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.1M Sell
439,952
-229,790
-34% -$2.07M ﹤0.01% 1397
2025
Q4 		$6M Sell
669,742
-242,557
-27% -$2.29M 0.01% 1073
2025
Q3 		$8.68M Buy
+912,299
New +$9.15M 0.01% 970
2024
Q4 		– Sell
-52,077
Closed -$361K – 3102
2024
Q3 		$361K Buy
+52,077
New +$353K ﹤0.01% 2057
2021
Q4 		– Sell
-109,936
Closed -$1.03M – 4443
2021
Q3 		$1.03M Buy
109,936
+92,783
+541% +$935K 0.01% 2001
2021
Q2 		$220K Buy
+17,153
New +$184K ﹤0.01% 2419

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return